SAN DIEGO, May 26, 2015 (GLOBE NEWSWIRE) -- Entra Health today announced a range of new product and service offerings that further sharpen the company's focus on providing fully integrated solutions for cloud-based analytics and remote patient monitoring in the clinical research space. Entra Health continues to integrate their Platform-as-a-Service (PaaS) architecture with a growing range of remote patient monitoring solutions including their proprietary MyGlucoHealth wireless blood glucose meter, as well as clinical grade weight scales, blood pressure monitors, pulse oximeters and other wireless biometric devices.
“Entra Health expanded on our FDA-approved platform for diabetes management and has grown into a one-stop solution for remote patient monitoring, telemedicine and mobile health,” said Richard Strobridge, CEO & Co-founder of Entra Health. “We have become the international market leader in wireless glucose data collection for clinical trials, and are expanding into heart failure and hypertension. Today, our customers include pharma, providers, payers, integrators and clinical research organizations. We provide clinical-grade devices and connectivity, data analytics and interoperability, along with the logistics and support for clinical trials around the world.”
The Entra Health FDA Class II and 21 CFR Part 11 platform is called MyHealthPoint and features independent Patient, Caregiver, Clinician and Analyst portals with the flexibility to track and direct specific information to each audience. The platform is engineered for universal EHR integration to streamline clinical workflow and provide clinicians with data that can help identify potential issues. When used in clinical research, the system improves titration, and rewards investigators with more timely and accurate data directly from patients' homes.
About Entra Health
Entra Health is a leading solution provider of high-quality, cloud-based remote patient monitoring, telehealth, health data exchange and analytics solutions. Entra Health’s secure Platform-as-a-Service (“PaaS”) remote patient monitoring solutions and devices have regulatory approval in 50 countries. The company is an international leader in wireless biometric data collection for clinical trials. For more information visit: www.entrahealth.com or call 877-458-2646.
Media Contact Bruce Ahern, Chief Marketing Officer Entra Health Systems 877-458-2646 x709 email@example.com
Source:Entra Health Systems